Results 211 to 220 of about 86,774 (261)

Ferulic Acid Modulates High Glucose-Induced MMP-1/TIMP-1 Imbalance and Enhances Wound Closure of Human Gingival Fibroblasts. [PDF]

Biomedicines
Özdemir A, Yüncü A, Yılmaz AM, Öztürk Özener H.   +3 more
europepmc   +1 more source

Temporal evolution of synovial histopathology in rheumatoid arthritis across treatment periods: a large-scale analysis of 1770 surgical specimens using the Rooney score. [PDF]

RMD Open
Sudo M, Abe A, Ishikawa H, Otsuka S, Takamura S, Kobayashi D, Nakazono K, Murasawa A, Yamamoto S, Ito S.   +9 more
europepmc   +1 more source

Di-Lineage Hepatic Spheroids From Human Donors Capture Steatotic Liver Disease. [PDF]

Cell Mol Gastroenterol Hepatol
Dutta T, Kovooru L, Thorsell A, Pujia C, Maurotti S, Sasidharan K, Mancina RM, Romeo S.   +7 more
europepmc   +1 more source

Atrial cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala, Monika Przewłocka‐Kosmala   +1 more
wiley   +1 more source

Protective Effects of Antioxidant Mix Pre-Treatment Against Visible Light-Induced Damage in Dark Skin Phototype. [PDF]

Antioxidants (Basel)
Guiotto A, Alghamdi M, Hickerson R, Conneely M, Choudhary H, Brieva P, Lim Y, Pecorelli A, Valacchi G.   +8 more
europepmc   +1 more source

Proteomic and glycosylation biomarkers in rheumatoid arthritis: advancing early diagnosis and precision therapy. [PDF]

Clin Proteomics
Sharma P, Aman S, Koundal P, Mohammed SA, Kaur H, Ahmad F, Khatoon S, Haque S, Hussain A.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Matrix metalloproteinase‐2 regulates the expression of tissue inhibitor of matrix metalloproteinase‐2

Clinical and Experimental Pharmacology and Physiology, 2010
Summary1. Matrix metalloproteinases (MMP) are associated with the vascular remodelling seen in atherosclerosis and aneurysm. The activation and activity of MMP‐2 are regulated by the intrinsic tissue inhibitor of MMP‐2 (TIMP‐2). The aim of the present study was to examine whether, conversely, MMP‐2 can affect the gene and protein expression of TIMP‐2.2.
Kaoru, Kimura, Xian Wu, Cheng, Kae, Nakamura, Aiko, Inoue, Lina, Hu, Haizhen, Song, Kenji, Okumura, Akihisa, Iguchi, Toyoaki, Murohara, Masafumi, Kuzuya   +9 more
openaire   +2 more sources

Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium

Fertility and Sterility, 2002
To investigate expression of matrix metalloproteinase-2 (MMP-2), membranous type 1 matrix metalloproteinase (MT1-MMP), and tissue inhibitor of metalloproteinase-2 (TIMP-2) in ectopic and eutopic endometrium from women with and without endometriosis throughout the menstrual cycle.Molecular studies in human tissue.Reproductive immunology laboratory of a ...
Hye-Sung Moon, Mi Hye Park, Mary Lake Polan   +2 more
exaly   +3 more sources

Polymorphisms in the matrix metalloproteinase‐2 and tissue inhibitor of metalloproteinase‐2 and the risk of human adenomyosis

Environmental and Molecular Mutagenesis, 2008
AbstractThe matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) may contribute to the development of adenomyosis. The aim of the present study was to investigate whether three single nucleotide polymorphisms (SNPs) in the promoter regions of MMP‐2 (−1306C/T and −735C/T) and TIMP‐2 (‐418G/C) genes were related to the risk
Shan, Kang, Xiwa, Zhao, Huimin, Xing, Na, Wang, Rongmiao, Zhou, Shucheng, Chen, Wansheng, Li, Jian, Zhao, Yanan, Duan, Donglan, Sun, Yan, Li   +10 more
openaire   +2 more sources